Advanced search
Publication Cover
Journal of Asthma and Allergy Volume 12, 2019 - Issue
Submit an article Journal homepage
329
Views
10
CrossRef citations to date
0
Altmetric
Review

Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications

Ilaria PuxedduClinical Immunology Unit, Department of Clinical and Experimental Medicine, Pisa University, Pisa, ItalyCorrespondence[email protected]
,
Fiorella PetrelliClinical Immunology Unit, Department of Clinical and Experimental Medicine, Pisa University, Pisa, Italy
,
Francesca AngelottiClinical Immunology Unit, Department of Clinical and Experimental Medicine, Pisa University, Pisa, ItalyORCID Iconhttps://orcid.org/0000-0001-5479-1790
ORCID Icon,
Cristina CroiaClinical Immunology Unit, Department of Clinical and Experimental Medicine, Pisa University, Pisa, Italy
&
Paola MiglioriniClinical Immunology Unit, Department of Clinical and Experimental Medicine, Pisa University, Pisa, Italy
Pages 285-295 | Published online: 20 Sep 2019

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Riccardo Asero & Massimo Cugno. (2021) Biomarkers of chronic spontaneous urticaria and their clinical implications. Expert Review of Clinical Immunology 17:3, pages 247-254.
Read now

Articles from other publishers (9)

Carolina Gómez Núñez, David Godoy Sánchez & Fernando Valenzuela Ahumada. (2023) ¿Qué hay de nuevo sobre los biomarcadores en urticaria crónica espontánea? Revisión de la literatura de los últimos años. Parte 1: etiopatogenia, diagnóstico, pronóstico y severidad. Piel 38:6, pages 394-401.
Crossref
E.V. Burygina, Y.I. Kozlova, E.V. Frolova, A.E. Uchevatkina, O.V. Aak, L.V. Filippova, A.V. Melnikova, K.I. Raznatovsky, N.V. Vasilyeva & N.N. Klimko. (2023) Current features of diagnosing the autoimmune type of chronic spontaneous urticaria in clinical practice. Klinicheskaya dermatologiya i venerologiya 22:2, pages 186.
Crossref
David M. Lang. (2022) Chronic Urticaria. New England Journal of Medicine 387:9, pages 824-831.
Crossref
Emek Kocatürk, Emel Bülbül Başkan, Özlem Su Küçük, Mustafa Özdemir, Sinem Örnek, Pelin Kuteyla Can, Eda Haşal, Burhan Engin, Nilgün Atakan & Erkan Alpsoy. (2022) Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?. Anais Brasileiros de Dermatologia 97:5, pages 592-600.
Crossref
Fiorella Petrelli, Daiana Giannini, Silvia Bilia, Isabella Del Corso, Valeria Rocchi, Paola Migliorini & Ilaria Puxeddu. (2022) Efficacy and safety of omalizumab therapy in urticaria vasculitis. Frontiers in Allergy 3.
Crossref
Manyun Mao, Hong Liu, Siyu Yan, Yan Yuan, Runqiu Liu, Yingfang Wu, Cong Peng, Jie Li & Xiang Chen. (2020) Plasma adenosine is linked to disease activity and response to treatment in patients with chronic spontaneous urticaria. Allergy 76:2, pages 571-573.
Crossref
Öykü Üzülmez, Tanja Kalic & Heimo Breiteneder. (2020) Advances and novel developments in molecular allergology. Allergy 75:12, pages 3027-3038.
Crossref
Teresa Grieco, Laura Dies, Alvise Sernicola, Camilla Chello, Nazareno Gagliostro, Giorgia Carnicelli & Giovanni Paolino. (2020) Potential clinical and serological predictors of chronic spontaneous urticaria relapse in patients under omalizumab treatment. Immunotherapy 12:16, pages 1173-1181.
Crossref
Laura Diluvio, Arianna Piccolo, Francesco Marasco, Laura Vollono, Caterina Lanna, Barbara Chiaramonte, Cinzia Niolu, Elena Campione & Luca Bianchi. (2020) Improving of psychological status and inflammatory biomarkers during omalizumab for chronic spontaneous urticaria. Future Science OA, pages FSO618.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.